» Articles » PMID: 29221266

Prognostic Impact of Controlling Nutritional Status Score in Resected Lung Squamous Cell Carcinoma

Abstract

Background: The preoperative immune-nutritional status has been shown to predict the postoperative prognosis in various types of cancer; however, the prognostic significance of the controlling nutritional status (CONUT) score in resected lung squamous cell carcinoma (SCC) has yet to be elucidated.

Methods: A total of 108 patients with resected lung SCC were analyzed for their clinicopathological factors, including the CONUT score, which can be calculated from the serum albumin, total cholesterol, and total peripheral lymphocyte count. The patients were divided into two groups: CONUT low (0 or 1) or high (≥2).

Results: Among 108 patients, 76 (70.4%) were CONUT low, while 32 (29.6%) were CONUT high. No significant association between the CONUT score and the clinicopathological factors was found. Patients with CONUT high exhibited significantly shorter disease-free and overall survivals (DFS and OS) than those with CONUT low (P=0.016 and P=0.006, respectively). Multivariate analyses showed that the CONUT score [hazard ratio (HR): 1.902, 95% confidence interval (CI): 1.045-3.373, P=0.036], age (HR: 2.286, 95% CI: 1.246-4.304, P=0.007), pathological stage (HR: 2.527, 95% CI: 1.391-4.644, P=0.002), and lymphatic invasion (HR: 2.321, 95% CI: 1.110-4.493, P=0.027) were independent prognostic factors for the DFS. Furthermore, in a multivariate analysis, the CONUT score (HR: 1.909, 95% CI: 0.902-3.860, P=0.081), age (HR: 2.455, 95% CI: 1.208-5.178, P=0.013), pathological stage (HR: 2.488, 95% CI: 1.201-5.306, P=0.014), and lymphatic invasion (HR: 3.409, 95% CI: 1.532-7.240, P=0.004) were shown to be independent prognostic factors for the OS.

Conclusions: The current study showed that the CONUT score was an independent prognostic factor for the DFS and OS in patients with resected lung SCC.

Citing Articles

Impact of Nutritional Changes on the Prognosis in Pancreatic Cancer Patients Underwent Curative Surgery After Neoadjuvant Chemotherapy.

Park S, Choi G, Lee I, Seo Y, Chae Y, Yun W Nutrients. 2025; 17(4).

PMID: 40004975 PMC: 11858578. DOI: 10.3390/nu17040647.


The Significance of an Initial Controlling Nutritional Status Score in Predicting the Functional Outcome, Complications, and Mortality in a First-Ever Ischemic Stroke.

Choi H, Jo Y, Sohn M, Lee J, Shin Y, Oh G Nutrients. 2024; 16(20).

PMID: 39458457 PMC: 11509889. DOI: 10.3390/nu16203461.


The Controlling Nutritional Status (CONUT) Score is a Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with First-Line Platinum-Based Chemotherapy.

Suzuki H, Ito M, Takemura K, Kobayashi S, Kataoka M, Iida N Bladder Cancer. 2024; 7(1):13-21.

PMID: 38993214 PMC: 11181873. DOI: 10.3233/BLC-200354.


The CONUT score is associated with the pathologic grade in non-small cell lung cancer.

Onodera K, Notsuda H, Watanabe T, Watanabe Y, Suzuki T, Hirama T Surg Today. 2024; 54(12):1437-1444.

PMID: 38709286 PMC: 11582223. DOI: 10.1007/s00595-024-02860-8.


Preoperative controlling nutritional status as an optimal prognostic nutritional index to predict the outcome for colorectal cancer.

Liu L, Wang H, Gao B, Xu T, Yuan Q, Zhou S World J Gastrointest Oncol. 2024; 16(2):343-353.

PMID: 38425394 PMC: 10900155. DOI: 10.4251/wjgo.v16.i2.343.


References
1.
Tokunaga R, Sakamoto Y, Nakagawa S, Ohuchi M, Izumi D, Kosumi K . CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection. Int J Colorectal Dis. 2016; 32(1):99-106. DOI: 10.1007/s00384-016-2668-5. View

2.
Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K . Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer. PLoS One. 2015; 10(7):e0132488. PMC: 4492767. DOI: 10.1371/journal.pone.0132488. View

3.
Sheng J, Yang Y, Ma Y, Qin T, Hu Z, Hong S . Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs. PLoS One. 2016; 11(1):e0147226. PMC: 4718699. DOI: 10.1371/journal.pone.0147226. View

4.
Cengiz O, Kocer B, Surmeli S, Santicky M, Soran A . Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma?. Med Sci Monit. 2006; 12(6):CR240-7. View

5.
de Ulibarri Perez J, Fernandez G, Rodriguez Salvanes F, Diaz Lopez A . Nutritional screening; control of clinical undernutrition with analytical parameters. Nutr Hosp. 2014; 29(4):797-811. DOI: 10.3305/nh.2014.29.4.7275. View